2022
DOI: 10.1111/aor.14242
|View full text |Cite
|
Sign up to set email alerts
|

Technology landscape of pediatric mechanical circulatory support devices: A systematic review 2010–2021

Abstract: Background: Mechanical circulatory support (MCS) devices, such as ventricular assist devices (VADs) and total artificial hearts (TAHs), have become a vital therapeutic option in the treatment of end-stage heart failure for adult patients.Such therapeutic options continue to be limited for pediatric patients. Clinicians initially adapted or scaled existing adult devices for pediatric patients; however, these adult devices are not designed to support the anatomical structure and varying flow capacities required … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
9
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 91 publications
(218 reference statements)
0
9
0
Order By: Relevance
“…MCS devices, such as ventricular assist devices (VADs) and total artificial hearts (TAHs) have been employed to support pediatric patients with some success ( 12 ). The Berlin Heart EXCOR (Berlin Heart, Berlin Germany) has been employed for thousands of pediatric patients, and Abbott Laboratories received U.S. FDA labeling for use of the HeartMate III in older pediatric patients with advanced refractory left ventricular HF in December 2020.…”
Section: Clinical Significance and Motivationmentioning
confidence: 99%
“…MCS devices, such as ventricular assist devices (VADs) and total artificial hearts (TAHs) have been employed to support pediatric patients with some success ( 12 ). The Berlin Heart EXCOR (Berlin Heart, Berlin Germany) has been employed for thousands of pediatric patients, and Abbott Laboratories received U.S. FDA labeling for use of the HeartMate III in older pediatric patients with advanced refractory left ventricular HF in December 2020.…”
Section: Clinical Significance and Motivationmentioning
confidence: 99%
“…The shortage of donor organs and the further difficulty of donor-recipient size matching create hurdles for cardiac transplantation and extend patients' waiting periods. To address these challenges, alternative treatment strategies are employed to provide bridge-to-transplant circulatory support in the form of a blood pump [13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…The usage of adult blood pumps for pediatric patients leads to “off-design” pressures and flows, which increases the risk of hemolysis, thromboemboli, and neurologic insult. 8,10…”
mentioning
confidence: 99%
“…5,6 Implementation of pediatric MCS is expected to continue due to the high survival rate (74% at 6 months). [7][8][9][10] The lack of appropriately designed pediatric devices, however, forces clinical teams to utilize adult-intended blood pumps. The usage of adult blood pumps for pediatric patients leads to "offdesign" pressures and flows, which increases the risk of hemolysis, thromboemboli, and neurologic insult.…”
mentioning
confidence: 99%
See 1 more Smart Citation